Subcribe RSS Feed
Lymphangioleiomyomatosis (LAM) Foundation Research Grants: Post Doctoral Fellowship Awards, Established Investigator Awards, and Pilot Project Awards
The LAM Foundation Research Grants:
The LAM Foundation is the global leader in the fight against Lymphangioleiomyomatosis (LAM): funding research, providing education and support. The Foundation began in 1995 as a grass roots effort and has evolved into an organization that is described by the National Heart, Lung, and Blood Institute (NHLBI) as "a model for voluntary health agencies." Headquartered in Cincinnati, Ohio, the Foundation is the only LAM organization which embodies all of the elements required to move LAM research from the laboratory to the clinic. The Foundation embraces women with LAM and their families, provides support and education, engages scientists and doctors, and raises funds for the study of LAM. With research as its central mission, the Foundation has elevated LAM from the ranks of rare and forgotten diseases to the forefront of pulmonary medicine. The LAM Foundation funded the first LAM research that resulted in the fundamental understanding of the genetic cause of LAM and the dawn of
previously unthinkable hope: the first-ever LAM treatment trial!
*The LAM Post Doctoral Fellowship Awards provide a maximum of $50,000 per year renewable for up to two additional years. More than 50% of the funds must be used for fellow salary support, and the maximum fellow salaries allowed are based on NIH guidelines for postdoctoral fellows. The balance of the funds may be used for fringe benefits, supplies, or
animal costs. No overhead or indirect costs are provided. Funds not spent are to be returned to The LAM Foundation at the end of each funding year.
*The LAM Established Investigator Awards provide a maximum of $50,000 per year renewable for up to two additional years. The structure and terms of this award are identical to the LAM Fellowship Award except that with the LAM Established Award, faculty level investigators are eligible to receive funding for technician support and supplies.
*The LAM Pilot Project Awards of up to $25,000 are also available for the initiation of innovative research projects. Candidates must have at least two years of experience, an MD, PhD, or equivalent degree, and perform the work in a laboratory with established expertise in smooth muscle biology or the genetics of tuberous sclerosis. Examples of competitive LAM proposals include those that focus on the genetic regulation of smooth muscle growth or the development of a smooth muscle cell line that is representative of the LAM lesion. Mechanistic,
hypotheses driven approaches of all types are welcomed. Formalin-fixed LAM tissues, dispersed LAM lung cells, genetic probes and other reagents are available.
Scientists who which to apply for LAM Foundation funding must submit a Letter of Intent (LOI). Letters of Intent for the fall deadline must reach The LAM Foundation by July 30th.
For more information and the LOI form:
http://www.thelamfoundation.org/LAM_physicians.htm#research
The LAM Foundation is the global leader in the fight against Lymphangioleiomyomatosis (LAM): funding research, providing education and support. The Foundation began in 1995 as a grass roots effort and has evolved into an organization that is described by the National Heart, Lung, and Blood Institute (NHLBI) as "a model for voluntary health agencies." Headquartered in Cincinnati, Ohio, the Foundation is the only LAM organization which embodies all of the elements required to move LAM research from the laboratory to the clinic. The Foundation embraces women with LAM and their families, provides support and education, engages scientists and doctors, and raises funds for the study of LAM. With research as its central mission, the Foundation has elevated LAM from the ranks of rare and forgotten diseases to the forefront of pulmonary medicine. The LAM Foundation funded the first LAM research that resulted in the fundamental understanding of the genetic cause of LAM and the dawn of
previously unthinkable hope: the first-ever LAM treatment trial!
*The LAM Post Doctoral Fellowship Awards provide a maximum of $50,000 per year renewable for up to two additional years. More than 50% of the funds must be used for fellow salary support, and the maximum fellow salaries allowed are based on NIH guidelines for postdoctoral fellows. The balance of the funds may be used for fringe benefits, supplies, or
animal costs. No overhead or indirect costs are provided. Funds not spent are to be returned to The LAM Foundation at the end of each funding year.
*The LAM Established Investigator Awards provide a maximum of $50,000 per year renewable for up to two additional years. The structure and terms of this award are identical to the LAM Fellowship Award except that with the LAM Established Award, faculty level investigators are eligible to receive funding for technician support and supplies.
*The LAM Pilot Project Awards of up to $25,000 are also available for the initiation of innovative research projects. Candidates must have at least two years of experience, an MD, PhD, or equivalent degree, and perform the work in a laboratory with established expertise in smooth muscle biology or the genetics of tuberous sclerosis. Examples of competitive LAM proposals include those that focus on the genetic regulation of smooth muscle growth or the development of a smooth muscle cell line that is representative of the LAM lesion. Mechanistic,
hypotheses driven approaches of all types are welcomed. Formalin-fixed LAM tissues, dispersed LAM lung cells, genetic probes and other reagents are available.
Scientists who which to apply for LAM Foundation funding must submit a Letter of Intent (LOI). Letters of Intent for the fall deadline must reach The LAM Foundation by July 30th.
For more information and the LOI form:
http://www.thelamfoundation.org/LAM_physicians.htm#research
posted by Editor @ 7/31/2007
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home
Support the Fellowship Board